Should I buy or sell Schrödinger stock right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Schrödinger in the last year. There are currently 3 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" SDGR shares. View SDGR analyst ratings or view top-rated stocks .

What is Schrödinger's stock price target for 2024?

9 brokerages have issued twelve-month price objectives for Schrödinger's shares. Their SDGR share price targets range from $26.00 to $67.00. On average, they predict the company's stock price to reach $43.50 in the next year. This suggests a possible upside of 79.1% from the stock's current price. View analysts price targets for SDGR or view top-rated stocks among Wall Street analysts .

How have SDGR shares performed in 2024?

Schrödinger's stock was trading at $35.80 at the beginning of the year. Since then, SDGR shares have decreased by 32.2% and is now trading at $24.29. View the best growth stocks for 2024 here .

When is Schrödinger's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024. View our SDGR earnings forecast .

How can I listen to Schrödinger's earnings call?

Schrödinger will be holding an earnings conference call on Wednesday, May 1st at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link .

How were Schrödinger's earnings last quarter?

Schrödinger, Inc. (NASDAQ:SDGR) posted its quarterly earnings results on Wednesday, February, 28th. The company reported ($0.32) earnings per share for the quarter, beating analysts' consensus estimates of ($0.44) by $0.12. The business earned $74.10 million during the quarter, compared to analyst estimates of $79.12 million. Schrödinger had a net margin of 18.79% and a negative trailing twelve-month return on equity of 23.58%. The firm's revenue for the quarter was up 30.5% on a year-over-year basis. During the same period last year, the business earned ($0.39) EPS.

What ETFs hold Schrödinger's stock?

ETFs with the largest weight of Schrödinger (NASDAQ:SDGR) stock in their portfolio include Northern Lights Fund Trust IV - Long Cramer Tracker ETF (LJIM) , ARK Genomic Revolution ETF (ARKG) , Subversive Mental Health ETF (SANE) , TrueShares Technology, AI & Deep Learning ETF (LRNZ) , Franklin Genomic Advancements ETF (HELX) , Invesco S&P SmallCap Health Care ETF (PSCH) , Range Cancer Therapeutics ETF (CNCR) and Loncar China Biopharma ETF (CHNA) .

What guidance has Schrödinger issued on next quarter's earnings?

Schrödinger updated its FY 2024 earnings guidance on Wednesday, February, 28th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $198.7 million-$214.8 million, compared to the consensus revenue estimate of $275.8 million.

What is Ramy Farid's approval rating as Schrödinger's CEO?

8 employees have rated Schrödinger Chief Executive Officer Ramy Farid on Glassdoor.com . Ramy Farid has an approval rating of 95% among the company's employees. This puts Ramy Farid in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Schrödinger own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Schrödinger investors own include NVIDIA (NVDA) , Marvell Technology (MRVL) , Tesla (TSLA) , Advanced Micro Devices (AMD) , Alibaba Group (BABA) , Block (SQ) , Cisco Systems (CSCO) , Teladoc Health (TDOC) , Alteryx (AYX) and QUALCOMM (QCOM) .

When did Schrödinger IPO?

Schrödinger (SDGR) raised $150 million in an IPO on Thursday, February 6th 2020. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley, BofA Securities, Jefferies and BMO Capital Markets acted as the underwriters for the IPO.

Who are Schrödinger's major shareholders?

Schrödinger's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Sumitomo Mitsui Trust Holdings Inc. (3.03%), Allspring Global Investments Holdings LLC (0.23%), TrueMark Investments LLC (0.06%), Los Angeles Capital Management LLC (0.02%) and GAMMA Investing LLC (0.00%). Insiders that own company stock include David E Shaw , Jenny Herman, Joel Lebowitz , Karen Akinsanya , Kenneth Patrick Lorton, Nancy Thornberry, Ramy Farid, Robert Lorne Abel , Rosana Kapeller-Libermann and Yvonne Tran . View institutional ownership trends .

How do I buy shares of Schrödinger?

Shares of SDGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:SDGR

Schrödinger (SDGR) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free SDGR Stock Alerts

$24.29

-0.05 (-0.21%)

(As of 04/19/2024 ET)

Compare

Today's Range: $23.94
▼
$24.58
50-Day Range: $24.29
▼
$33.09
52-Week Range: $20.76
▼
$59.24

Volume: 620,364 shs
Average Volume: 859,640 shs
Market Capitalization: $1.76 billion

P/E Ratio: 38.56
Dividend Yield: N/A
Price Target: $43.50

Get Schrödinger alerts:

Schrödinger MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.67 Rating Score
Upside/Downside: 79.1% Upside
$43.50 Price Target
Short Interest: Bearish
8.63% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.63
Based on 3 Articles This Week
Insider Trading: Selling Shares
$102,395 Sold Last Quarter
Proj. Earnings Growth: Growing
From ($2.73) to ($1.94) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.56 out of 5 stars

Medical Sector

254th out of 911 stocks

Pharmaceutical Preparations Industry

102nd out of 411 stocks

4.3

Analyst's Opinion

Consensus Rating
Schrödinger has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 6 buy ratings, 3 hold ratings, and no sell ratings.
Amount of Analyst Coverage
Schrödinger has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

1.0

Short Interest

Percentage of Shares Shorted
8.63% of the outstanding shares of Schrödinger have been sold short.
Short Interest Ratio / Days to Cover
Schrödinger has a short interest ratio ("days to cover") of 6.9.
Change versus previous month
Short interest in Schrödinger has recently increased by 5.41%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Schrödinger does not currently pay a dividend.
Dividend Growth
Schrödinger does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for SDGR.

3.1

News and Social Media Coverage

News Sentiment
Schrödinger has a news sentiment score of 0.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.52 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for Schrödinger this week, compared to 2 articles on an average week.
Search Interest
Only 12 people have searched for SDGR on MarketBeat in the last 30 days. This is a decrease of -40% compared to the previous 30 days.
MarketBeat Follows
16 people have added Schrödinger to their MarketBeat watchlist in the last 30 days. This is an increase of 23% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Schrödinger insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $102,395.00 in company stock.
Percentage Held by Insiders
Only 7.60% of the stock of Schrödinger is held by insiders.
Percentage Held by Institutions
79.05% of the stock of Schrödinger is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9

Earnings and Valuation

Earnings Growth
Earnings for Schrödinger are expected to grow in the coming year, from ($2.73) to ($1.94) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Schrödinger is 38.56, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 145.54.
Price to Earnings Ratio vs. Sector
The P/E ratio of Schrödinger is 38.56, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 269.16.
Price to Book Value per Share Ratio
Schrödinger has a P/B Ratio of 3.20. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Crypto 101 Media

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

About Schrödinger Stock (NASDAQ:SDGR)

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

SDGR Stock Price History

30 days | 90 days | 365 days | Advanced Chart

SDGR Stock News Headlines

April 18, 2024 | businesswire.com

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

April 12, 2024 | americanbankingnews.com

Schrödinger (NASDAQ:SDGR) Trading Down 7.7%

April 20, 2024 | Paradigm Press (Ad)

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

April 11, 2024 | finance.yahoo.com

Institutional investors must be pleased after a 11% gain last week that adds to Schrödinger, Inc.'s (NASDAQ:SDGR) one-year returns

April 11, 2024 | americanbankingnews.com

Schrödinger, Inc. (NASDAQ:SDGR) Receives Average Recommendation of "Moderate Buy" from Analysts

April 10, 2024 | businesswire.com

Schrödinger to Announce First Quarter 2024 Financial Results on May 1

April 2, 2024 | investorplace.com

5 Healthcare Stocks to Buy for 2024

April 1, 2024 | msn.com

9 Noteworthy Stocks in Bill Gates’ Portfolio

April 20, 2024 | Paradigm Press (Ad)

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

March 27, 2024 | investorplace.com

Invest Like Bill Gates With These 3 AI Stocks to Buy

March 20, 2024 | investorplace.com

Shhh! 7 Small-Cap Stocks That Can Double by 2025

March 1, 2024 | investorplace.com

The Hot List: 3 AI Stocks Worth Buying on Weakness

February 29, 2024 | seekingalpha.com

Schrodinger: Conservative Guidance Sets The Stock Up For A Solid 2024

February 29, 2024 | markets.businessinsider.com

Buy Rating Affirmed for Schrodinger Amidst Robust Software Business and Promising Clinical Milestones

February 29, 2024 | markets.businessinsider.com

Piper Sandler Keeps Their Buy Rating on Schrodinger (SDGR)

February 29, 2024 | finance.yahoo.com

Schrödinger, Inc. (NASDAQ:SDGR) Q4 2023 Earnings Call Transcript

February 29, 2024 | msn.com

Shoals Technologies Posts Weak Q4 Results, Joins Butterfly Network, Schrödinger And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

February 28, 2024 | msn.com

Schrodinger down 15% after hours on soft 2024 guidance

February 28, 2024 | finance.yahoo.com

Schrödinger Reports Strong Fourth Quarter and Full-Year 2023 Financial Results

February 28, 2024 | msn.com

Schrödinger Non-GAAP EPS of -$0.32 beats by $0.04, revenue of $74.1M misses by $5.02M

February 28, 2024 | finance.yahoo.com

Schrodinger Inc (SDGR) Reports Strong Revenue Growth in Q4 and Full-Year 2023

February 22, 2024 | finance.yahoo.com

SDGR Jun 2024 20.000 call

February 22, 2024 | finance.yahoo.com

SDGR Apr 2024 40.000 call

February 22, 2024 | finance.yahoo.com

SDGR Jan 2025 65.000 put

February 22, 2024 | benzinga.com

Schrodinger Stock (NASDAQ:SDGR), Analyst Ratings, Price Targets, Predictions

February 20, 2024 | finance.yahoo.com

SDGR Jan 2026 55.000 put

February 19, 2024 | investorplace.com

Double Your Money: 3 Growth Stocks to Grab in 2024

See More Headlines

Receive SDGR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Schrödinger and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/28/2024
Today: 4/19/2024
Next Earnings (Confirmed): 5/01/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: NASDAQ:SDGR
CUSIP: N/A
CIK: 1490978
Web: www.schrodinger.com
Phone: 212-295-5800
Fax: N/A
Employees: 867
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $43.50
High Stock Price Target: $67.00
Low Stock Price Target: $26.00
Potential Upside/Downside: +79.0%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.67
Research Coverage: 9 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.63
Trailing P/E Ratio: 38.57
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $40.72 million
Net Margins: 18.79%
Pretax Margin: 19.81%
Return on Equity: -23.58%
Return on Assets: -16.65%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 4.25
Quick Ratio: 4.25

Sales & Book Value

Annual Sales: $216.67 million
Price / Sales: 8.11
Cash Flow: $0.62 per share
Price / Cash Flow: 39.04
Book Value: $7.60 per share
Price / Book: 3.20

Miscellaneous

Outstanding Shares: 72,310,000
Free Float: 66,815,000
Market Cap: $1.76 billion
Optionable: Optionable
Beta: 1.57

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

Dr. Ramy Farid Ph.D. (Age 58)
CEO, President & Director
Comp: $1.04M
Dr. Richard A. Friesner Ph.D. (Age 71)
Co-Founder, Scientific Advisory Chairman and Director
Comp: $455k
Dr. Geoffrey Craig Porges MBBS
Executive VP & CFO
Ms. Yvonne Tran Esq. (Age 53)
Chief Legal & People Officer
Comp: $670.1k
Dr. Robert Lorne Abel Ph.D. (Age 41)
Executive VP, Chief Scientific Officer of Platform and Head of Modeling R&D
Comp: $528.37k
Dr. Karen Akinsanya Ph.D. (Age 56)
President of Research & Development Therapeutics
Comp: $777.68k
Ms. Jenny Herman
Senior VP of Finance & Corporate Controller
Prof. William Goddard III
Co-Founder & Scientific Advisor
Mr. Kenneth Patrick Lorton (Age 40)
Executive VP, CTO & COO of Software
Comp: $510.09k
Mr. Shane Brauner (Age 46)
Executive VP & Chief Information Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

SDGR Stock Analysis - Frequently Asked Questions

Should I buy or sell Schrödinger stock right now?: 9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Schrödinger in the last year. There are currently 3 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" SDGR shares.
View SDGR analyst ratings or view top-rated stocks.
What is Schrödinger's stock price target for 2024?: 9 brokerages have issued twelve-month price objectives for Schrödinger's shares. Their SDGR share price targets range from $26.00 to $67.00. On average, they predict the company's stock price to reach $43.50 in the next year. This suggests a possible upside of 79.1% from the stock's current price.
View analysts price targets for SDGR or view top-rated stocks among Wall Street analysts.
How have SDGR shares performed in 2024?: Schrödinger's stock was trading at $35.80 at the beginning of the year. Since then, SDGR shares have decreased by 32.2% and is now trading at $24.29.
View the best growth stocks for 2024 here.
When is Schrödinger's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our SDGR earnings forecast.
How can I listen to Schrödinger's earnings call?: Schrödinger will be holding an earnings conference call on Wednesday, May 1st at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.
How were Schrödinger's earnings last quarter?: Schrödinger, Inc. (NASDAQ:SDGR) posted its quarterly earnings results on Wednesday, February, 28th. The company reported ($0.32) earnings per share for the quarter, beating analysts' consensus estimates of ($0.44) by $0.12. The business earned $74.10 million during the quarter, compared to analyst estimates of $79.12 million. Schrödinger had a net margin of 18.79% and a negative trailing twelve-month return on equity of 23.58%. The firm's revenue for the quarter was up 30.5% on a year-over-year basis. During the same period last year, the business earned ($0.39) EPS.
What ETFs hold Schrödinger's stock?: ETFs with the largest weight of Schrödinger (NASDAQ:SDGR) stock in their portfolio include Northern Lights Fund Trust IV - Long Cramer Tracker ETF (LJIM), ARK Genomic Revolution ETF (ARKG), Subversive Mental Health ETF (SANE), TrueShares Technology, AI & Deep Learning ETF (LRNZ), Franklin Genomic Advancements ETF (HELX), Invesco S&P SmallCap Health Care ETF (PSCH), Range Cancer Therapeutics ETF (CNCR) and Loncar China Biopharma ETF (CHNA).

What guidance has Schrödinger issued on next quarter's earnings?: Schrödinger updated its FY 2024 earnings guidance on Wednesday, February, 28th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $198.7 million-$214.8 million, compared to the consensus revenue estimate of $275.8 million.
What is Ramy Farid's approval rating as Schrödinger's CEO?: 8 employees have rated Schrödinger Chief Executive Officer Ramy Farid on Glassdoor.com. Ramy Farid has an approval rating of 95% among the company's employees. This puts Ramy Farid in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Schrödinger own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Schrödinger investors own include NVIDIA (NVDA), Marvell Technology (MRVL), Tesla (TSLA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Block (SQ), Cisco Systems (CSCO), Teladoc Health (TDOC), Alteryx (AYX) and QUALCOMM (QCOM).
When did Schrödinger IPO?: Schrödinger (SDGR) raised $150 million in an IPO on Thursday, February 6th 2020. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley, BofA Securities, Jefferies and BMO Capital Markets acted as the underwriters for the IPO.
Who are Schrödinger's major shareholders?: Schrödinger's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Sumitomo Mitsui Trust Holdings Inc. (3.03%), Allspring Global Investments Holdings LLC (0.23%), TrueMark Investments LLC (0.06%), Los Angeles Capital Management LLC (0.02%) and GAMMA Investing LLC (0.00%). Insiders that own company stock include David E Shaw, Jenny Herman, Joel Lebowitz, Karen Akinsanya, Kenneth Patrick Lorton, Nancy Thornberry, Ramy Farid, Robert Lorne Abel, Rosana Kapeller-Libermann and Yvonne Tran.
View institutional ownership trends.
How do I buy shares of Schrödinger?: Shares of SDGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:SDGR) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Schrödinger (SDGR) Stock Price, News & Analysis

Schrödinger MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Schrödinger Stock (NASDAQ:SDGR)

SDGR Stock Price History

SDGR Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

SDGR Stock Analysis - Frequently Asked Questions

Overall MarketRank^™